Skip to main content
. 2021 Jan 20;22(3):1015. doi: 10.3390/ijms22031015

Table 1.

Gastrointestinal adverse events. Relevant symptoms for the four investigated drugs were selected from http://drugcentral.org/ (LR: Likelihood ratio).

Category MedDRA
Adverse Event Term
LR
Donepezil
LR
Rivastigmine
LR
Galantamine
LR
Memantine
Eating behavior Decreased appetite 335.24 127.75 67.45 199.77
Dehydration 154.16 134.20 - 160.69
Diet refusal - - - 44.01
Dysphagia - 145.45 - 63.51
Eating disorder - 44.27 - 48.36
Hypophagia 63.10 - - 43.76
Malaise - 280.04 - 105.56
Nausea 144.38 315.48 - 77.11
Salivary hypersecretion 53.98 - - -
Weight decreased 54.62 124.86 - 89.91
Gastrointestinal dysfunction Anal incontinence 48.70 - - -
Constipation - - - 76.09
Diarrhoea 163.56 132.59 - -
Faecaloma - - - 40.77
Gastric ulcer 62.65 - -
Gastrointestinal haemorrhage 99.75 41.61 - -
Gastrointestinal disorder - 65.65 - -
Duodenal ulcer 79.33 - -
Melaena 43.41 - - -
Upper gastrointestinal haemorrhage 49.68 - - -
Vomiting 332.71 438.03 55.85 104.10
Pancreatic/hepatic dysfunction Aspartate aminotransferase ↑ - - - 68.31
Alanine aminotransferase ↑ - - - 56.78
Blood alkaline phosphatase ↑ - - - 68.56
Hepatic function abnormal 63.00 - - -
Hepatitis - 47.10 - 56.62
Pancreatitis - - - 53.69
Pancreatitis acute - - - 97.25

↑: elevated.